Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Psoriasis × deucravacitinib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis 1 Prostatic Neoplasms 1

Interventions

Etanercept 3 Methotrexate 2 Adalimumab 2 secukinumab 1 purine 1 fumaric acid 1 deucravacitinib 1 apremilast 1 Vitamin D 1 Vaccines 1 Sulfasalazine 1 Standard of Care 1 Saline Solution 1 Practice Guidelines as Topic 1 Nivolumab 1 Methods 1 Mesalamine 1 Mercaptopurine 1 Interviews as Topic 1 Infliximab 1 Herpes Zoster Vaccine 1 Folic Acid 1 Fish Oils 1 Fatty Acids, Omega-3 1 Exercise 1 Eicosapentaenoic Acid 1 Educational Status 1 Eating 1 Early Intervention, Educational 1 Docosahexaenoic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06281106 2025-04-02

TYPP

Centre Hospitalier Universitaire Vaudois

Phase 2/3 Terminated

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡